Pharma Stocks
-
{
- All
- News
- Videos
-
Pakistan Faces Critical Medicine Shortage Amid Import Disruptions, Only 45 Days Of Supply Remain
Pakistan faces critical medicine shortages as Middle East conflict disrupts imports of pharmaceutical raw materials and essential supplies.
-
Nifty Falls Below 25,000, Sensex Slips Under 82,000 In Early Trade
Indian stock markets came under pressure on Friday as selling by Foreign Portfolio Investors (FPIs) weighed on investor sentiment.
-
Sensex, Nifty Open Flat After US Federal Policy Decision
The Indian benchmark indices opened almost flat on Thursday over the US Federal Reserve policy decision and weak Asian cues, as selling was seen in the IT, PSU bank, FMCG and pharma sectors in the early trade.
-
Sensex Falls 231 Points, Nifty Downs 49 Points Amid Mixed Global Cues
The domestic benchmark indices opened lower on Friday amid mixed global cues as selling was seen in the IT, financial services and pharma sectors in the early trade.
-
Sensex Opens 265 Points Higher, Nifty Climbs 89 Points In Early Trade
The Indian equity benchmark indices opened higher on Friday amid positive global cues, as buying was seen in the IT, pharma and auto sectors in the early trade.
-
Maharashtra Drug Regulator Seizes Medicine That Claims To "Cure" Diabetes
The Maharashtra Food and Drug Administration (FDA) has seized stocks of a medicine that makes misleading claim to cure diabetes after raiding the premises of a pharma distributor here, FDA officials said on Wednesday.
-
Delhi Will Need Oxygen If Supply (Taxes) Stopped (From Maharashtra): Sena
The Shiv Sena on Monday slammed BJP leaders Devendra Fadnavis and Pravin Darekar for objecting to Mumbai police's grilling of a pharma firm's top executive over alleged stocking of Remdesivir vials.
-
PSU Banks Drag Markets; Sensex Slumps 430 Points To Close At 33,317 Level, Nifty Settles Below 10,250
The top drags in the Sensex pack were Sun Pharma, State Bank of India, ICICI Bank, Mahindra & Mahindra and Maruti Suzuki.
-
Sun Pharma Stock In Focus After Q3 Profit Falls 75%
Motilal Oswal maintains 'buy' rating on Sun Pharma Stock, while Edelweiss downgrades the scrip rating to 'Hold' from 'Buy'
-
Amid Caution, These Stocks Lose Upto 8% In Run Up To RBI Policy
Natco Pharma, Vakrangee, Redington, NTPC and HCL Technologies posted heavy losses on Wednesday.
-
Pakistan Faces Critical Medicine Shortage Amid Import Disruptions, Only 45 Days Of Supply Remain
Pakistan faces critical medicine shortages as Middle East conflict disrupts imports of pharmaceutical raw materials and essential supplies.
-
Nifty Falls Below 25,000, Sensex Slips Under 82,000 In Early Trade
Indian stock markets came under pressure on Friday as selling by Foreign Portfolio Investors (FPIs) weighed on investor sentiment.
-
Sensex, Nifty Open Flat After US Federal Policy Decision
The Indian benchmark indices opened almost flat on Thursday over the US Federal Reserve policy decision and weak Asian cues, as selling was seen in the IT, PSU bank, FMCG and pharma sectors in the early trade.
-
Sensex Falls 231 Points, Nifty Downs 49 Points Amid Mixed Global Cues
The domestic benchmark indices opened lower on Friday amid mixed global cues as selling was seen in the IT, financial services and pharma sectors in the early trade.
-
Sensex Opens 265 Points Higher, Nifty Climbs 89 Points In Early Trade
The Indian equity benchmark indices opened higher on Friday amid positive global cues, as buying was seen in the IT, pharma and auto sectors in the early trade.
-
Maharashtra Drug Regulator Seizes Medicine That Claims To "Cure" Diabetes
The Maharashtra Food and Drug Administration (FDA) has seized stocks of a medicine that makes misleading claim to cure diabetes after raiding the premises of a pharma distributor here, FDA officials said on Wednesday.
-
Delhi Will Need Oxygen If Supply (Taxes) Stopped (From Maharashtra): Sena
The Shiv Sena on Monday slammed BJP leaders Devendra Fadnavis and Pravin Darekar for objecting to Mumbai police's grilling of a pharma firm's top executive over alleged stocking of Remdesivir vials.
-
PSU Banks Drag Markets; Sensex Slumps 430 Points To Close At 33,317 Level, Nifty Settles Below 10,250
The top drags in the Sensex pack were Sun Pharma, State Bank of India, ICICI Bank, Mahindra & Mahindra and Maruti Suzuki.
-
Sun Pharma Stock In Focus After Q3 Profit Falls 75%
Motilal Oswal maintains 'buy' rating on Sun Pharma Stock, while Edelweiss downgrades the scrip rating to 'Hold' from 'Buy'
-
Amid Caution, These Stocks Lose Upto 8% In Run Up To RBI Policy
Natco Pharma, Vakrangee, Redington, NTPC and HCL Technologies posted heavy losses on Wednesday.
